These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23235665)

  • 1. Optimal loading dose of warfarin for the initiation of oral anticoagulation.
    Mahtani KR; Heneghan CJ; Nunan D; Bankhead C; Keeling D; Ward AM; Harrison SE; Roberts NW; Hobbs FD; Perera R
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD008685. PubMed ID: 23235665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal loading dose for the initiation of warfarin: a systematic review.
    Heneghan C; Tyndel S; Bankhead C; Wan Y; Keeling D; Perera R; Ward A
    BMC Cardiovasc Disord; 2010 Apr; 10():18. PubMed ID: 20403189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
    Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin initiation nomograms for venous thromboembolism.
    Garcia P; Ruiz W; Loza Munárriz C
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD007699. PubMed ID: 26822633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin initiation nomograms for venous thromboembolism.
    Garcia P; Ruiz W; Loza Munarriz C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD007699. PubMed ID: 23839808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
    Stergiopoulos K; Brown DL
    JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.
    Bruins Slot KM; Berge E
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008980. PubMed ID: 23925867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of genotype-guided dosing of warfarin.
    Pirmohamed M; Burnside G; Eriksson N; Jorgensen AL; Toh CH; Nicholson T; Kesteven P; Christersson C; Wahlström B; Stafberg C; Zhang JE; Leathart JB; Kohnke H; Maitland-van der Zee AH; Williamson PR; Daly AK; Avery P; Kamali F; Wadelius M;
    N Engl J Med; 2013 Dec; 369(24):2294-303. PubMed ID: 24251363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
    Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
    PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.
    Gedge J; Orme S; Hampton KK; Channer KS; Hendra TJ
    Age Ageing; 2000 Jan; 29(1):31-4. PubMed ID: 10690692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.
    Tse G; Gong M; Li G; Wong SH; Wu WKK; Wong WT; Roever L; Lee APW; Lip GYH; Wong MCS; Liu T;
    Br J Clin Pharmacol; 2018 Sep; 84(9):1868-1882. PubMed ID: 29704269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.
    Yang T; Zhou Y; Chen C; Lu M; Ma L; Cui Y
    J Clin Pharm Ther; 2019 Apr; 44(2):197-208. PubMed ID: 30593674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial.
    Schulman S; Hwang HG; Eikelboom JW; Kearon C; Pai M; Delaney J
    J Thromb Haemost; 2014 Aug; 12(8):1254-9. PubMed ID: 24837794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.
    Tang HL; Shi WL; Li XG; Zhang T; Zhai SD; Xie HG
    Pharmacogenomics J; 2015 Dec; 15(6):496-504. PubMed ID: 25869011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy.
    Suwanawiboon B; Kongtim P; Chinthammitr Y; Ruchutrakool T; Wanachiwanawin W
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S225-31. PubMed ID: 21721451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
    Higashi MK; Veenstra DL; Kondo LM; Wittkowsky AK; Srinouanprachanh SL; Farin FM; Rettie AE
    JAMA; 2002 Apr; 287(13):1690-8. PubMed ID: 11926893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.